| Name | Title | Contact Details |
|---|
We are a biopharmaceutical company developing first-in-class therapies for cancer. Imetelstat, a novel, first-in-class telomerase inhibitor, is our product candidate in clinical development. Telomerase enables cancer cells to maintain telomere length, which provides them with the capacity for limitless cellular replication. Imetelstat is a potent and specific inhibitor of telomerase. Based on clinical data we obtained in late 2012, we may develop imetelstat to treat one or more hematologic myeloid malignancies such as myelofibrosis, or MF, myelodysplastic syndromes, or acute myelogenous leukemia.
Advent Advisory Group is a Astoria, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
AccentHealth is a New York, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Homecare America is a Jupiter, FL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Advanced ENT and Allergy is a Louisville, KY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.